Please login to the form below

Not currently logged in

DH appoints new board members

Dr Catherine Bell and Dr David Heymann are to join the departmental board of the UK's Department of Health as non-executive board members

Dr Catherine Bell and Dr David Heymann are to join the departmental board of the UK's Department of Health (DH) as non-executive board members.

Dr Heymann, who has previously worked for the Centres for Disease Control and Prevention (USA) and the World Health Organisation (WHO), is currently chair of the Health Protection Agency (HPA), an independent body in the UK set up in 2003 to provide advice and information to the public and healthcare professionals about infectious diseases and environmental hazards.

As announced in October 2010, the HPA is one of 11 DH-related bodies to be abolished by the coalition government as part of efforts to reform the way public services are managed.

With his appointment lasting until April 2012, Heymann will support the transfer of the agency's functions to the DH with plans to incorporate its services into Public Health England - a dedicated public health service proposed in the Health and Social Care Bill.

Dr Bell, whose previous roles in Whitehall include being permanent secretary of the Department of Trade and Industry, is governor of the London School of Economics and chair of the Investment Committee of the Civil Service Benevolent Fund.

Both Dr Bell and Dr Heymann will help the DH oversee health reforms in England, with board duties including providing advice to ministers on the strategy and objectives for the health and social care system; setting DH standards and establishing frameworks for governance and management of risk.

Current board members include chief medical officer, Dame Sally Davies, and Sir David Nicholson, chief executive of the NHS.

26th January 2011

From: Healthcare


COVID-19 Updates and Daily News

Featured jobs


Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...